Skip to main content
Premium Trial:

Request an Annual Quote

NeuroNova Awarded US Patent

Premium
NeuroNova has been awarded US Patent 7,320,872, “Ependymal neural stem cells and method for their isolation.”
 
The inventors listed on the patent are Ann Marie Janson, Jonas Frisen, Clas Johansson, Stefan Momma, Diana Clarke, Ming Zhao, Urban Lendahl, and Kioumars Delfani.
 
According to the abstract, the patent describes an ependymal neural CNS stem cell, which expresses the surface protein Notch 1 together with at least one surface protein chosen from the group of Notch 2, Notch 3, CAR (transmembrane protein binding adenovirus), and CFTR (cystic fibrosis transmembrane conductance regulator). The cell also comprises at least one cilium. The patent also describes preparations, including pharmaceutical preparations, comprising ependymal neural CNS stem cells; in vitro and in vivo assays based on these cells; and various other uses of the cells.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.